Cart
sales@molnova.com
WAY-325398
CAS No. 445231-36-7
WAY-325398( —— )
Catalog No. M37671 CAS No. 445231-36-7
WAY-325398 is a furan derivatives. WAY-325398 inhibits osteoclast formation, inhibition rate is 14.11% at 10 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 263 | In Stock |
|
| 2MG | 166 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2111 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-325398
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-325398 is a furan derivatives. WAY-325398 inhibits osteoclast formation, inhibition rate is 14.11% at 10 μM.
-
DescriptionAnti-osteoporosis agent-6 (compound 174) is an anti-osteoporosis agent. Anti-osteoporosis agent-6 has 14.11% inhibition rate against osteoclast formation at 10 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number445231-36-7
-
Formula Weight357.79
-
Molecular FormulaC19H16ClNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC1=C(Cl)C=CC=C1)(=O)C=2OC(COC3=C(OC)C=CC=C3)=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jung-Keun Kim, et al. Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same. Patent, WO2004037804A1.
molnova catalog
related products
-
Epieudesmin
(+)-Epieudesmin is an antineoplastic agent. (+)-Epieudesmin has marginal cancer cell line inhibitory activities. (+)-Epieudesmin inhibits the growth of Gram-negative pathogen.
-
[Tyr0] - α - CGRP, h...
[Tyr0] - α - CGRP, human
-
FB23
FB23 directly binds to FTO and selectively inhibits FTO's m6A demethylase activity. (FTO, an mRNA N6-methyladenosine (m6A) demethylase, was reported to promote leukemogenesis.)
